KRTL Holding Group, Inc., now known as QUEENCH, Inc., (OTC: QENC) is pleased to announce its wholly owned subsidiary, KRTL Biotech, Inc. ("Biotech") has engaged Daniel Ball as its new Chief Executive Officer. He comes to Biotech bringing a wealth of knowledge of the Oregon, Washington, and Californian hemp and cannabis markets, experience as a regulatory consultant on now emerging-psilocybin legislation in Oregon, and an IP holder for several key technologies to support Biotech's international biotechnology efforts and revenue generation potential.
Biotech's COO, Cesar Herrera, said, "We are fortunate to have a person with extraordinary industry and finance skills join the Biotech team. Daniel Ball is an operations technologist and avid entrepreneur, with expertise in blockchain, telecommunications, AI, and ISO-level environmental testing for hemp and cannabis. He started his operations leadership in the Fortune 500 space with telecom company T-Mobile, where he led the training and launch of specialized technology teams and business units in support of the first smartphones and the US’s first rollout of a fiberoptic-backed 4G network.”
Mr. Ball later joined the U.S. Army as a Signals Intelligence Analyst, where he thrived due to his foundation in telecom. He was introduced to distributed ledger technology (DLT) applications (the origin of today's blockchain platforms) and rose quickly as a subject matter expert on all things digital communications where he wrote several whitepapers and tradecraft documents on crossover integration between DLT and modern networks like digital mobile radio. As a non-commissioned officer for a counterterrorism unit, he was placed over several key intelligence efforts and managed the deployment of over $250 million of ground and airborne assets, spending much of his time on the operational integration of complex technology platforms requiring compliance for various jurisdictions and regulatory bodies.
After leaving the military, Daniel leveraged his strength as a leader in multi-theater operations optimization and helped a friend and colleague launch one of Oregon's first full suite cannabis and hemp testing laboratories. He integrated key processing optimization strategies and state-of-the art technology to raise efficiencies and become a state-leader in testing fidelity and turnaround time, dropping the average cannabis compliance test-completion from 12 business days to 4 business days and growing their starting company revenue by over 1,200% within 15 months, making it one of the first cannabis-focused testing labs to break above a $50 million valuation in that newly regulated market, all while navigating complex and quickly changing regulations, product marketplace inconsistency, and strict ORELAP and OLCC guidelines. Later, those efforts would culminate in obtaining ISO 17025 accreditation through A2LA, the gold standard in environmental testing labs across the nation.
Since that time, he has founded several companies, successfully exited a few, and helped launch several more. Most recently, his focus has been the utilization and practical integration of forward-edge technology like AI and blockchain to solve significant global issues in the medical (medtech), agricultural (agritech), and IT networking sectors assisting the U.S. Department of Defense, other government agencies, and Fortune 500 companies.
Once again, Biotech welcomes Mr. Daniel Ball to the team.
About KRTL Holding Group, Inc.
We translate strategy into action by combining our time-tested expertise in strategic planning, portfolio management, project execution, marketing, disruptive innovation, and organizational engagement to provide a progressive, revolutionary approach to transforming your organization. The Company manages its subsidiaries with precision and excellence that continues to create and strengthen KRTL’s reputation. This allows KRTL Holding Group to capitalize on any range of investment opportunities. Our organization values collaboration and emphasizes a transparent work environment.
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.